# Alirocumab and Plaque Burden In Familial Hypercholesterolaemia

> **NCT05465278** · PHASE4 · COMPLETED · sponsor: **Fundación Hipercolesterolemia Familiar** · enrollment: 104 (actual)

## Conditions studied

- Familial Hypercholesterolemia

## Interventions

- **DRUG:** Alirocumab

## Key facts

- **NCT ID:** NCT05465278
- **Lead sponsor:** Fundación Hipercolesterolemia Familiar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2022-03-30
- **Final completion:** 2022-03-30
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2022-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05465278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05465278, "Alirocumab and Plaque Burden In Familial Hypercholesterolaemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05465278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*